此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

POC - Transfusion Algorithm Cardiac Study (TACS)

2016年12月1日 更新者:Jo Carroll、University Health Network, Toronto

Blood Conservation in Cardiac Surgery Using a Novel Transfusion Algorithm Based on Point-of-care Testing-A Stepped-wedge Cluster Randomized Controlled Trial

This multi-centre study will provide sound, generalizable data on the effectiveness of a POC-based algorithm to determine to what extent this guideline can reduce blood product transfusions. Investigators will study outcomes in 7000 patients undergoing heart surgery at 10 participating hospitals. The proposed trial addresses several important research and clinical issues and has the potential to markedly improve the transfusion management and surgical care in general of cardiac surgery patients.

The intervention will be a novel POC-based algorithm that has been shown in a pilot study by us to be associated with a substantial reduction in blood product transfusions. The algorithm will employ viscoelastic and aggregometric POC-tests and an objective measure of blood loss. The primary outcome will be avoidance of red blood cell transfusion during hospitalization. The study has a 90% power to detect a 12% increase in avoidance rate. Secondary outcomes will include avoidance of red blood cell use and other blood products (plasma, platelets, and cryoprecipitate), units of blood products transfused, and adverse clinical outcomes related to transfusion (acute kidney injury, infections, and death). Data will also be collected for future health-economics analyses.

Largely due to the limitations of existing evidence, however, such algorithms are rarely used in clinical practice. The proposed trial will provide sound, generalizable data on the effectiveness of a POC-based algorithm to guide their future use. An integrated blood management algorithm that employs POC coagulation tests will reduce blood product transfusions in cardiac surgery, thereby improving clinical outcomes.

Does an integrated blood transfusion algorithm that employs POC coagulation tests applied across a network of hospitals reduce blood transfusions and associated adverse outcomes in cardiac surgery?

研究概览

地位

完全的

条件

详细说明

Despite major advances in cardiac surgery, coagulopathy continues to carry a heavy burden in cases that require the use of cardiopulmonary bypass (CPB), occurring frequently and resulting in excessive blood loss, blood product transfusions, and adverse clinical outcomes. Current management of coagulopathy is hampered by the inability of conventional laboratory tests to delineate its etiology in a timely manner, thereby precluding timely and targeted transfusion therapy. With the advent of point-of-care (POC) coagulation tests that can rapidly identify the etiology of coagulopathy, it may now be possible to reduce the burden of coagulopathy and thereby reduce transfusions and adverse outcomes. Several single-centre studies (including one by the investigator group) have found that the use of POC-based algorithms in cardiac surgery can markedly reduce blood product transfusions and by that means reduce morbidities and mortality.

研究类型

介入性

注册 (实际的)

7402

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Alberta
      • Calgary、Alberta、加拿大、T2N 2T9
        • Dr. Charles McAdams
      • Edmonton、Alberta、加拿大
        • Blaine Achen
    • British Columbia
      • Vancouver、British Columbia、加拿大、V5Z 1M9
        • Dr. Terry Waters
      • Vancouver、British Columbia、加拿大
        • Dr. Sukhpal Brar
    • Manitoba
      • Winnipeg、Manitoba、加拿大、R2H 2A6
        • Dr. H. Grocott
    • Ontario
      • Hamilton、Ontario、加拿大、L8N 3Z5
        • Dr. Summer Syed
      • London、Ontario、加拿大、N6A 5A5
        • Dr. Christopher Harle
      • Newmarket、Ontario、加拿大、L3Y 2P9
        • Dr. Daniel Kim
      • Ottawa、Ontario、加拿大、K1Y 4W7
        • Dr. D. Tran
      • Toronto、Ontario、加拿大、M4N 3M5
        • Dr. F. Moussa
    • Quebec
      • Fleurimont、Quebec、加拿大、J1H 5N4
        • Dr. E. Medicis
      • Sainte -Foy、Quebec、加拿大、G1V 4G5
        • Dr. J. Bussieres

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Hospital Inclusion:

  • Participating hospitals must not currently be using a POC-based blood conservation algorithm; must have an in-hospital RBC transfusion rate of > 35% and platelet or plasma transfusion rates of > 20%; must conduct > 600 cardiac surgeries employing CPB per year; and must have commitments from departments of Anesthesia, Cardiac Surgery, and Laboratory Medicine to support the study and to abide by the algorithm
  • Blood transfusion algorithm instituted as standard-of-care at participating hospitals
  • All adult (≥ 18 years) patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) will be included in the analysis.

Exclusion Criteria: Hospitals not meeting inclusion.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
其他:Transfusion Algorithm
Hospitals will be randomized to the intervention arm of the study in a stratified manner.
A transfusion algorithm based on point-of-care coagulation testing.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Point Of Care (POC) Transfusion Algorithm Cardiac Study
大体时间:2.5 years
The primary outcome measure will be the proportion of patients who receive any allogeneic red blood cell (RBC) transfusion from admission before surgery to end of follow-up.
2.5 years

次要结果测量

结果测量
措施说明
大体时间
Transfusion
大体时间:7 days
Allogeneic blood products (platelets, plasma, cryoprecipitate) or coagulation factors (e.g., fibrinogen concentrate, factor VIIa), or undergo re-exploration; units of blood products transfused, nadir hemoglobin concentration (to identify changes in transfusion practice that may be unrelated to treatment of coagulopathy)
7 days
Blood loss
大体时间:24 hours
Chest-tube drainage at 6 and 24 hours after surgery
24 hours
Ventilation and hospital stay
大体时间:24 hours to 7 days
Duration of mechanical ventilation and length of stay in the ICU and hospital
24 hours to 7 days
Kidney injury
大体时间:48 hours
Incidence of acute kidney injury, defined as a ≥ 2-fold in increase in creatinine or new renal replacement therapy within 48 hours after surgery
48 hours
Post operative complications
大体时间:7 days
Arrhythmias, sternal infection, myocardial infarction, stroke, thromboembolic events, and death
7 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2014年10月1日

初级完成 (实际的)

2016年9月1日

研究完成 (实际的)

2016年9月1日

研究注册日期

首次提交

2014年6月20日

首先提交符合 QC 标准的

2014年7月24日

首次发布 (估计)

2014年7月25日

研究记录更新

最后更新发布 (估计)

2016年12月5日

上次提交的符合 QC 标准的更新

2016年12月1日

最后验证

2016年12月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅